Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -3.593.8626.35-4.601.38

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is -3.59 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-3.59
Mar20233.86
Mar202226.35
Mar2021-4.60
Mar20201.38

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35
Positive
Mar2021 -4.6
Negative
Mar2020 1.38 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹523.0 Cr -0.2% -4% -9.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹121,260.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -0.5% -0.1% -5.1% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-0.2%

-4%

-9.4%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses